# US 2017/0253923 A1 · Method for nanopore rna characterisation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0253923 A1
- Document ID: US20170253923A1
- Status: Published application
- Kind: A1
- Application number: 15/519,599
- Filed: 2015-10-19
- Published: 2017-09-07
- Earliest claimed: 2014-10-17
- Assignees: Oxford Nanopore Technologies PLC
- Applicants: Oxford Nanopore Technologies Ltd.
- Inventors: Daniel Ryan Garalde; Andrew John Heron; Lakmal Jayasinghe; Daniel John Turner; James White
- Web page: https://patentgrep.com/patent/US20170253923A1

## CPC

- C12Q 1/6869: Methods for sequencing
- C12N 9/14: Hydrolases (3)
- C12Y 306/04012: DNA helicase (3.6.4.12)
- G01N 27/44791: {Microapparatus (sample containers with integrated microfluidic structures B01L3/5027)}
- G01N 33/48721: {Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68)}
- C12Q 2565/631: being a biochannel or pore
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention relates to a new method of characterising FIG. 3 a target RNA polynucleotide by taking one or more measurements as the target RNA polynucleotide moves with respect to a transmembrane pore. The movement is controlled by a DNA helicase. The invention also relates to a modified RNA construct wherein the RNA polynucleotide has been modified to increase DNA helicase binding thereto.

## Claims

### Claim 1

A method of characterising a target RNA polynucleotide comprising:
a) providing (i) an RNA polynucleotide wherein the RNA polynucleotide is modified to comprise a non-RNA polynucleotide and (ii) a DNA helicase enzyme;
b) contacting the RNA polynucleotide and DNA helicase enzyme provided in a) with a transmembrane pore such that the DNA helicase controls the movement of the RNA polynucleotide through the transmembrane pore;
c) taking one or more measurements as the RNA polynucleotide moves with respect to the transmembrane pore, wherein the measurements are indicative of one or more characteristics of the RNA polynucleotide, and thereby characterising the target RNA polynucleotide.

### Claim 2 (depends on 1)

A method according to claim 1 wherein the non-RNA polynucleotide comprises a DNA helicase binding site or a DNA adaptor.

### Claim 3 (depends on 2)

A method according to claim 2 wherein the DNA helicase binding site or the DNA adaptor comprises a leader sequence.

### Claim 4 (depends on 3)

A method according to claim 3 wherein the leader sequence preferentially threads into the pore.

### Claim 5 (depends on 1)

A method according to claim 1 wherein the non-RNA polynucleotide is attached to the RNA polynucleotide by means of a covalent bond formed between at least one reactive group on each of the RNA polynucleotide and the non-RNA polynucleotide.

### Claim 6 (depends on 1)

A method according to claim 1 wherein the non-RNA polynucleotide is ligated to the RNA polynucleotide by chemical or enzymatic ligation.

### Claim 7 (depends on 1)

A method according to claim 1 wherein the non-RNA polynucleotide is hybridised to the RNA polynucleotide.

### Claim 8 (depends on 1)

A method according to claim 1, wherein the one or more characteristics are selected from (i) length of the RNA polynucleotide, (ii) identity of the RNA polynucleotide, (iii) the sequence of the RNA polynucleotide, (iv) the secondary structure of the RNA polynucleotide and (v) whether or not the RNA polynucleotide is modified.

### Claim 9 (depends on 1)

A method according to claim 1 wherein the one or more characteristics of the RNA polynucleotide are measured by electrical and/or optical measurement.

### Claim 10 (depends on 1)

A method according to claim 1, wherein step c) comprises measuring the current passing through the transmembrane pore as the RNA polynucleotide moves with respect to the transmembrane pore wherein the current is indicative of one or more characteristics of the RNA polynucleotide and thereby characterising the RNA polynucleotide.

### Claim 11 (depends on 1)

A method according to claim 1, wherein the RNA polynucleotide comprises modification by methylation, by oxidation, by damage, with one or more proteins, base analogues or with one or more labels, tags or spacers.

### Claim 12 (depends on 1)

A method according to claim 1, wherein the RNA polynucleotide is coupled to the membrane using one or more anchors.

### Claim 13 (depends on 1)

A method according to claim 1, wherein the DNA helicase comprises a modification to reduce the size of an opening in the polynucleotide binding domain through which in at least one conformational state the RNA polynucleotide can unbind from the helicase.

### Claim 14 (depends on 1)

A method according to claim 1, wherein the movement is controlled by a series of one of more DNA helicases.

### Claim 15 (depends on 1)

A method according to claim 1, wherein the one or more helicases are a) Hel308 helicases, RecD helicases, XPD helicases or Dda helicases (b) helicases derived from any of the helicases in (a); or (c) a combination of any of the helicases in (a) and/or (b).

### Claim 16 (depends on 1)

A method according to claim 1, further comprising one or more molecular brakes that are derived from helicases and are modified such that they bind the polynucleotide but do not function as a helicase.

### Claim 17 (depends on 1)

A method according to claim 1, wherein the transmembrane pore is a protein pore or a solid state pore.

### Claim 18 (depends on 17)

A method according to claim 17, wherein the transmembrane protein pore is a protein pore and is derived from a hemolysin, leukocidin, Mycobacterium smegmatis porin A (MspA), MspB, MspC, MspD, CsgG, lysenin, outer membrane porin F (OmpF), outer membrane porin G (OmpG), outer membrane phospholipase A, Neisseria autotransporter lipoprotein (NalP) and WZA.

### Claim 19

A method of moving a target RNA polynucleotide with respect to a transmembrane pore when the movement is controlled by a DNA helicase enzyme, comprising:
a) providing (i) an RNA polynucleotide wherein the RNA polynucleotide is modified to comprise a non-RNA polynucleotide and a (ii) a DNA helicase enzyme;
b) contacting the RNA polynucleotide and DNA helicase enzyme provided in a) with a transmembrane pore such that the DNA helicase controls the movement of the RNA polynucleotide with respect to the transmembrane pore.

### Claim 20 (depends on 19)

A method according to claim 19 wherein the method comprises before step (b) binding the DNA helicase enzyme to the modified RNA polynucleotide.

### Claim 21 (depends on 19)

A method according to claim 19, wherein the RNA polynucleotide is modified to comprise a DNA helicase binding site or a DNA adaptor.

### Claim 22 (depends on 19)

A method according to claim 19, wherein the method provides more consistent movement of the RNA polynucleotide with respect to the transmembrane pore.

### Claim 23

A polynucleotide comprising an RNA polynucleotide and DNA polynucleotide wherein the DNA polynucleotide comprises or comprises only a DNA helicase binding site.

### Claim 24 (depends on 23)

A polynucleotide according to claim 23 further comprising a leader sequence which preferentially threads into a nanopore.

### Claim 25 (depends on 23)

A polynucleotide according to claim 23 further comprising a barcoding section on the polynucleotide strand.

### Claim 26 (depends on 25)

A polynucleotide according to claim 25 wherein the barcoding section is located between the leader sequence and the DNA helicase binding site.

### Claim 27

A combination of an RNA polynucleotide and a DNA helicase in which a part of the RNA polynucleotide has been modified to comprise a non-RNA polynucleotide and interact with the DNA helicase.

### Claim 28

A kit for characterising a target RNA polynucleotide comprising a non-RNA polynucleotide which is adapted to attach to any target RNA polynucleotide for characterisation.
